Detalles de la búsqueda
1.
4-Aryl-4-oxo-N-phenyl-2-aminylbutyramides as acetyl- and butyrylcholinesterase inhibitors. Preparation, anticholinesterase activity, docking study, and 3D structure-activity relationship based on molecular interaction fields.
Bioorg Med Chem
; 18(3): 1181-93, 2010 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-20061157
2.
The in vitro protective effects of the three novel nanomolar reversible inhibitors of human cholinesterases against irreversible inhibition by organophosphorous chemical warfare agents.
Chem Biol Interact
; 309: 108714, 2019 Aug 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-31228470
3.
Weak intermolecular interactions in 11-chloro-2,3,4,5-tetrahydro-1H-cyclohepta[b]quinoline.
Acta Crystallogr C
; 64(Pt 9): o502-4, 2008 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-18758020
4.
Structural modifications of 4-aryl-4-oxo-2-aminylbutanamides and their acetyl- and butyrylcholinesterase inhibitory activity. Investigation of AChE-ligand interactions by docking calculations and molecular dynamics simulations.
Eur J Med Chem
; 81: 158-75, 2014 Jun 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-24836068
5.
(E)-4-aryl-4-oxo-2-butenoic acid amides, chalcone-aroylacrylic acid chimeras: design, antiproliferative activity and inhibition of tubulin polymerization.
Eur J Med Chem
; 62: 40-50, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23353745
6.
The 3D-QSAR study of 110 diverse, dual binding, acetylcholinesterase inhibitors based on alignment independent descriptors (GRIND-2). The effects of conformation on predictive power and interpretability of the models.
J Mol Graph Model
; 38: 194-210, 2012 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-23073222
Resultados
1 -
6
de 6
1
Próxima >
>>